<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02937883</url>
  </required_header>
  <id_info>
    <org_study_id>733050607</org_study_id>
    <nct_id>NCT02937883</nct_id>
  </id_info>
  <brief_title>Empowerment Intervention for Persons With Young Onset Dementia</brief_title>
  <official_title>Effects of an Empowerment Intervention for Community-dwelling Persons With Young Onset Dementia and Their Informal Caregivers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of an empowerment intervention for
      community-dwelling persons with young onset dementia and their informal caregivers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study focuses on the evaluation of an empowerment intervention developed for persons
      with young onset dementia and their informal caregivers. The empowerment intervention focuses
      on current capacities, maintenance of autonomy, and increasing the opportunities to feel
      useful. This pragmatic cluster randomized controlled trial aims to investigate (1) the
      effectiveness of the intervention concerning participants' well-being, quality of life, and
      behavioral issues, (2) the effect of the intervention on the informal caregivers' sense of
      competence and perceived distress, and (3) the impact of the intervention on healthcare
      costs. Furthermore, the investigators aim to study the feasibility of the intervention to
      frame an implementation strategy.

      Participants in the intervention group will receive the intervention for 5 months.
      Participants of the control group receive care as usual.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Actual">June 2018</completion_date>
  <primary_completion_date type="Actual">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in self-management abilities</measure>
    <time_frame>5 months</time_frame>
    <description>(Self-Management Ability Scale (SMAS))</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life</measure>
    <time_frame>5 months</time_frame>
    <description>(Quality of life - Alzheimer Disease scale (QOL-AD))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in neuropsychiatric symptoms Questionnaire</measure>
    <time_frame>5 months</time_frame>
    <description>(Neuropsychiatric Inventory (NPI-Q))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in disability</measure>
    <time_frame>5 months</time_frame>
    <description>(Interview for Deterioration in Daily living activities in Dementia (IDDD))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in apathy</measure>
    <time_frame>5 months</time_frame>
    <description>(abbreviated Apathy Evaluation Scale (AES-10))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver measures:Competence (</measure>
    <time_frame>5 months</time_frame>
    <description>Short Sense of Competence Questionnaire (SSCQ))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver measures: Emotional distress</measure>
    <time_frame>5 months</time_frame>
    <description>(NPI-Q distress score)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Analysis of qualitative focus group interviews with participants, caregivers and health care professionals</measure>
    <time_frame>5 months</time_frame>
    <description>Qualitative evaluation of the intervention</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Dementia</condition>
  <condition>Empowerment</condition>
  <arm_group>
    <arm_group_label>empowerment intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Empowerment intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>regular care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Regular care, care as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Empowerment intervention</intervention_name>
    <description>Empowerment intervention for persons with young onset dementia</description>
    <arm_group_label>empowerment intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with dementia before the age of 65

          -  Living at home (community-dwelling)

        Exclusion Criteria:

          -  Dementia is caused by Down's syndrome, Huntington's disease, HIV or alcohol-related
             dementia.

          -  Limited contact between the person with dementia and the informal caregiver (&lt;3 times
             a week)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond T CM Koopmans, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboudumc Nijmegen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Florence</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2016</study_first_posted>
  <last_update_submitted>August 30, 2018</last_update_submitted>
  <last_update_submitted_qc>August 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Daily Activities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

